Paediatric Clinic, University Hospital, Department of Medicine and Surgery, University of Parma, Parma, Italy.
Paediatrics and Neonatology Unit, Guglielmo da Saliceto Hospital, Piacenza, Italy.
J Glob Antimicrob Resist. 2022 Jun;29:499-506. doi: 10.1016/j.jgar.2021.11.003. Epub 2021 Nov 18.
Febrile urinary tract infection (UTI) is currently considered the most frequent cause of serious bacterial illness in children in the first 2 years of life. UTI in paediatrics can irreversibly damage the renal parenchyma and lead to chronic renal insufficiency and related problems. To avoid this risk, an early effective antibiotic treatment is essential. Moreover, prompt treatment is mandatory to improve the clinical condition of the patient, prevent bacteraemia, and avoid the risk of bacterial localization in other body sites. However, antibiotic resistance for UTI-related bacterial pathogens continuously increases, making recommendations rapidly outdated and the definition of the best empiric antibiotic therapy more difficult. Variation in pathogen susceptibility to antibiotics is essential for the choice of an effective therapy. Moreover, proper identification of cases at increased risk of difficult-to-treat UTIs can reduce the risk of ineffective therapy. In this review, the problem of emerging antibiotic resistance among pathogens associated with the development of paediatric febrile UTIs and the best potential solutions to ensure the most effective therapy are discussed. Literature analysis showed that the emergence of antibiotic resistance is an unavoidable phenomenon closely correlated with the use of antibiotics themselves. To limit the emergence of resistance, every effort to reduce and rationalise antibiotic consumption must be made. An increased use of antibiotic stewardship can be greatly effective in this regard.
发热性尿路感染(UTI)目前被认为是儿童生命前 2 年中最常见的严重细菌感染病因。儿科 UTI 可使肾实质不可逆地受损,导致慢性肾功能不全和相关问题。为了避免这种风险,早期有效的抗生素治疗至关重要。此外,及时治疗对于改善患者的临床状况、预防菌血症和避免细菌在其他身体部位定位至关重要。然而,与 UTI 相关的细菌病原体的抗生素耐药性不断增加,使得建议迅速过时,并且最佳经验性抗生素治疗的定义更加困难。抗生素耐药性是选择有效治疗的关键。此外,适当识别有发生治疗困难的 UTI 风险的病例可以降低治疗无效的风险。在这篇综述中,讨论了与儿科发热性 UTIs 发展相关的病原体中出现抗生素耐药性的问题,以及确保最有效治疗的最佳潜在解决方案。文献分析表明,抗生素耐药性的出现是一个不可避免的现象,与抗生素的使用密切相关。为了限制耐药性的出现,必须尽一切努力减少和合理化抗生素的使用。增加抗生素管理的使用可以在这方面发挥很大的作用。